CME
Is There a Role for Novel BCMA-Directed Cellular Therapies in Early Relapsed Multiple Myeloma?
Host: Joseph Mikhael, MD Recognizing and treating early relapse of multiple myeloma (MM) is a challenge for healthcare professionals. This program is designed to improve clinicians ability to distinguish between relapse and progression of disea